Consolidative therapy with stem cell transplantation improves survival of patients with mantle cell lymphoma after any induction regimen. [electronic resource]
Producer: 20120612Description: 359-66 p. digitalISSN:- 1873-2399
- Adult
- Aged
- Antibodies, Monoclonal, Murine-Derived -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Boronic Acids -- administration & dosage
- Bortezomib
- Consolidation Chemotherapy
- Cyclophosphamide -- administration & dosage
- Dexamethasone -- administration & dosage
- Disease-Free Survival
- Doxorubicin -- administration & dosage
- Female
- Humans
- Kaplan-Meier Estimate
- Lymphoma, Mantle-Cell -- drug therapy
- Male
- Middle Aged
- Peripheral Blood Stem Cell Transplantation
- Prednisone -- administration & dosage
- Pyrazines -- administration & dosage
- Remission Induction
- Retrospective Studies
- Rituximab
- Transplantation Conditioning -- methods
- Transplantation, Autologous
- Transplantation, Homologous
- Treatment Outcome
- Vincristine -- administration & dosage
No physical items for this record
Publication Type: Evaluation Study; Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.